The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Quercetin-induced apoptosis acts through mitochondrial- and caspase-3-dependent pathways in human breast cancer MDA-MB-231 cells
Abstract
There has been considerable evidence recently demonstrating the anti-tumour effects of flavonols. Quercetin, an ubiquitous bioactive flavonol, inhibits cells proliferation, induces cell cycle arrest and apoptosis in different cancer cell types. The precise molecular mechanism of quercetin-induced apoptosis in human breast cancer cells is unclear. The purpose of this study was to investigate effects of quercetin on cell viability and to determine its underlying mechanism in human breast cancer MDA-MB-231 cells. Quercetin decreased the percentage of viable cells in a dose- and time-dependent manner, which was associated with cell cycle arrest and apoptosis. Quercetin did not increase reactive oxygen species generation but increased cytosolic Ca 2+ levels and reduced the mitochondrial membrane potential (ΔΨ m). Quercetin treatment promoted activation of caspase-3, -8 and -9 in MDA-MB-231 cells. Caspase inhibitors prevented the quercetin-induced loss of cell viability. Quercetin increased abundance of the pro-apoptotic protein Bax and decreased the levels of anti-apoptotic protein Bcl-2. Confocal laser microscope examination indicated that quercetin promoted apoptosis-inducing factor (AIF) release from mitochondria and stimulated translocation to the nucleus. Taken together, these findings suggest that quercetin results in human breast cancer MDA-MB-231 cell death through mitochondrial- and caspase-3-dependent pathways.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Strasser, A., O'Connor, L., & Dixit, V. M. (2000) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.69.1.217 · Cited by 1,351
Haupt, S., Berger, M., Goldberg, Z., & Haupt, Y. (2003) · Journal of Cell Science · doi:10.1242/jcs.00739 · Cited by 1,136
Curcumin and cancer: An “old-age” disease with an “age-old” solution
Anand, P., Sundaram, C., Jhurani, S., Kunnumakkara, A. B., & Aggarwal, B. B. (2008) · Cancer Letters · doi:10.1016/j.canlet.2008.03.025 · Cited by 1,132
Targeting the Cell Cycle: A New Approach to Cancer Therapy
Schwartz, G. K., & Shah, M. A. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.01.5594 · Cited by 817
The Bcl-2 protein family: sensors and checkpoints for life-or-death decisions
Borner, C. (2003) · Molecular Immunology · doi:10.1016/s0161-5890(02)00252-3 · Cited by 703
Cell-cycle inhibitors: three families united by a common cause
Vidal, A., & Koff, A. (2000) · Gene · doi:10.1016/s0378-1119(00)00092-5 · Cited by 431
Granado-Serrano, A. B., Martiín, M. A., Bravo, L., Goya, L., & Ramos, S. (2006) · The Journal of Nutrition · doi:10.1093/jn/136.11.2715 · Cited by 374
Induction of cell cycle arrest and apoptosis in human breast cancer cells by quercetin
Choi, J.-A., Kim, J.-Y., Lee, J.-Y., Kang, C.-M., Kwon, H.-J., Yoo, Y.-D., Kim, T.-W., Lee, Y.-S., & Lee, S.-J. (2001) · International Journal of Oncology · doi:10.3892/ijo.19.4.837 · Cited by 363
Swanton, C. (2004) · The Lancet Oncology · doi:10.1016/s1470-2045(03)01321-4 · Cited by 248
Dietary Flavonoids and the Risk of Colorectal Cancer
Theodoratou, E., Kyle, J., Cetnarskyj, R., Farrington, S. M., Tenesa, A., Barnetson, R., Porteous, M., Dunlop, M., & Campbell, H. (2007) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-06-0785 · Cited by 231
Effect of flavonoids on cell cycle progression in prostate cancer cells
Kobayashi, T., Nakata, T., & Kuzumaki, T. (2002) · Cancer Letters · doi:10.1016/s0304-3835(01)00738-8 · Cited by 214
Lim, D. Y., Jeong, Y., Tyner, A. L., & Park, J. H. Y. (2007) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00248.2006 · Cited by 186
Flavonoids and Breast Cancer Risk in Italy
Bosetti, C., Spertini, L., Parpinel, M., Gnagnarella, P., Lagiou, P., Negri, E., Franceschi, S., Montella, M., Peterson, J., Dwyer, J., et al. (2005) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-04-0838 · Cited by 184
Novel antiproliferative flavonoids induce cell cycle arrest in human prostate cancer cell lines
Haddad, A. Q., Venkateswaran, V, Viswanathan, L., Teahan, S. J., Fleshner, N. E., & Klotz, L. H. (2006) · Prostate Cancer and Prostatic Diseases · doi:10.1038/sj.pcan.4500845 · Cited by 178
Independent origins of syringyl lignin in vascular plants
Weng, J.-K., Li, X., Stout, J., & Chapple, C. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0801696105 · Cited by 176
Quercetin arrests G2/M phase and induces caspase-dependent cell death in U937 cells
Lee, T.-J., Kim, O. H., Kim, Y. H., Lim, J. H., Kim, S., Park, J.-W., & Kwon, T. K. (2006) · Cancer Letters · doi:10.1016/j.canlet.2005.09.013 · Cited by 168
Yang, J.-H., Hsia, T.-C., Kuo, H.-M., Chao, P.-D. L., Chou, C.-C., Wei, Y.-H., & Chung, J.-G. (2006) · Drug Metabolism and Disposition · doi:10.1124/dmd.105.005280 · Cited by 165
Self-citationAnti-proliferative effect of apigenin and its apoptotic induction in human Hep G2 cells
Chiang, L., Ng, L., Lin, I.-C., Kuo, P., & Lin, C. (2005) · Cancer Letters · doi:10.1016/j.canlet.2005.06.002 · Cited by 150
Yang, J., Chen, G.-W., Hsia, T., Ho, H.-C., Ho, C.-C., Lin, M.-W., Lin, S., Yeh, R.-D., Ip, S., Lu, H. F., et al. (2008) · Food and Chemical Toxicology · doi:10.1016/j.fct.2008.10.032 · Cited by 120
Self-citationEnhanced anti-tumor effect of combination therapy with gemcitabine and apigenin in pancreatic cancer
Lee, S. H., Ryu, J. K., Lee, K.-Y., Woo, S. M., Park, J. K., Yoo, J. W., Kim, Y., & Yoon, Y. B. (2007) · Cancer Letters · doi:10.1016/j.canlet.2007.09.015 · Cited by 116
Mitochondria-cytochrome C-caspase-9 cascade mediates isorhamnetin-induced apoptosis
Lee, H., Lee, H., Lee, E., Ko, S., Bae, H., Kim, C.-H., Ahn, K.-S., Lü, J., & Kim, S. (2008) · Cancer Letters · doi:10.1016/j.canlet.2008.05.040 · Cited by 113
Chang, J., Hsu, Y., Kuo, P., Kuo, Y.-C., Chiang, L., & Lin, C. (2005) · Life Sciences · doi:10.1016/j.lfs.2004.11.003 · Cited by 107
Apigenin induces cell cycle arrest and p21/WAF1 expression in a p53-independent pathway
Takagaki, N., Sowa, Y., Oki, T., Nakanishi, R., Yogosawa, S., & Sakai, T. (2005) · International Journal of Oncology · doi:10.3892/ijo.26.1.185 · Cited by 104
Mu, C., Jia, P., Yan, Z., Liu, X., Li, X., & Liu, H. (2007) · Methods and Findings in Experimental and Clinical Pharmacology · doi:10.1358/mf.2007.29.3.1092095 · Cited by 102
Flavonoids and the Risk of Renal Cell Carcinoma
Bosetti, C., Rossi, M., McLaughlin, J. K., Negri, E., Talamini, R., Λάγιου, Π., Montella, M., Ramazzotti, V., Franceschi, S., & Vecchia, C. L. (2007) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-06-0769 · Cited by 88
Jin, C., Park, C., Cheong, J., Choi, B. T., Lee, T. H., Lee, J.-D., Lee, W. H., Kim, G., Ryu, C. H., & Choi, Y. H. (2007) · Cancer Letters · doi:10.1016/j.canlet.2007.06.019 · Cited by 77
Kim, S., Min, H., Chung, H., Park, E., Hong, J., Kang, Y.-J., Shin, D. H., Jeong, L. S., & Lee, S. K. (2008) · Cancer Letters · doi:10.1016/j.canlet.2008.01.037 · Cited by 57
Li, A., & Blow, J. J. (2001) · Nature Cell Biology · doi:10.1038/35087119 · Cited by 52
Kellner, C., & Zunino, S. J. (2004) · Cancer Letters · doi:10.1016/j.canlet.2004.06.046 · Cited by 34
Hsu, M.-H., Chen, C., Kuo, S., Chung, J., Lai, Y.-Y., Teng, C., Pan, S., & Huang, L.-J. (2006) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2006.12.001 · Cited by 25
Self-citation2′-Nitroflavone induces cell cycle arrest and apoptosis in HeLa human cervical carcinoma cells
Cárdenas, M., Blank, V. C., Marder, M., & Roguin, L. P. (2008) · Cancer Letters · doi:10.1016/j.canlet.2008.03.062 · Cited by 15
Hou, C., Fong, Y., Chen, J.-T., Liu, J., Lin, M.-S., Chang, C., & Tang, C. (2008) · Cancer Letters · doi:10.1016/j.canlet.2008.05.037 · Cited by 11
Cited by
Anticancer and apoptosis-inducing effects of quercetin in vitro and in vivo
Hashemzaei, M., Far, A. D., Yari, A., Heravi, R. E., Tabrizian, K., Taghdisi, S. M., Sadegh, S. E., Tsarouhas, K., Kouretas, D., Tzanakakis, G., et al. (2017) · Oncology Reports · doi:10.3892/or.2017.5766 · Cited by 520
High-mobility group box 1 and cancer
Tang, D., Kang, R., Zeh III, H. J., & Lotze, M. T. (2010) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2009.11.014 · Cited by 512
Quercetin and Cancer Chemoprevention
Gibellini, L., Pinti, M., Nasi, M., Montagna, J. P., De Biasi, S., Roat, E., Bertoncelli, L., Cooper, E. L., & Cossarizza, A. (2011) · Evidence-Based Complementary and Alternative Medicine · doi:10.1093/ecam/neq053 · Cited by 449
Vidya Priyadarsini, R., Senthil Murugan, R., Maitreyi, S., Ramalingam, K., Karunagaran, D., & Nagini, S. (2010) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2010.09.020 · Cited by 399
A review on anti-cancer properties of Quercetin in breast cancer
Ezzati, M., Yousefi, B., Velaei, K., & Safa, A. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.117463 · Cited by 356
Metadata
- Authors
- Chien, S.-Y., Wu, Y.-C., Chung, J.-G., Yang, J.-S., Lu, H.-F., Tsou, M.-F., Wood, W., Kuo, S.-J., & Chen, D.-R.
- Venue
- Human & Experimental Toxicology
- Publisher
- SAGE Publications
- Published
- 2009-08
- Volume
- 28
- Issue
- 8
- Pages
- 493-503
- ISSN
- 0960-3271 (ISSN-L)
- 1477-0903
- OpenAlex
- W1984833201
- Cited by
- 269
- References
- 32
- FWCI
- 9.61
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.